Aevi Genomic Medicine Competitors and Similar CompaniesClear all
AnGes's competitors and similar companies include Intellia Therapeutics and CRISPR Therapeutics.
 AnGes AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine. |  Intellia Therapeutics Intellia Therapeutics is a genome editing company that caters to the biotechnology industry. |  CRISPR Therapeutics CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases. | |
Founding Date | Founding Date 1999 | Founding Date 2014 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Ibaraki, JP HQ Fujisawa, JP Ibaraki, JP Kawasaki, JP Minato City, JP Bethesda, US | Locations Cambridge, US HQ | Locations Zug, CH HQ Greater London, GB Cambridge, US San Francisco, US |
Employees | Employees 5562% decrease | Employees 40323% decrease | Employees 393 |
Valuation ($) | Valuation ($) 78.3 m | Valuation ($) 1.7 b | Valuation ($) 4.2 b |
Financial | |||
Revenue (est.) | Revenue (est.) ¥874.1m (FY, 2025) | Revenue (est.) $67.7m (FY, 2025) | Revenue (est.) $3.5m (FY, 2025) |
Net income | Net income (¥5.1b) (FY, 2025) | Net income ($412.7m) (FY, 2025) | Net income ($581.6m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Intellia Therapeutics
HQ
Cambridge, US
Employees
403↓ 23% decrease
Intellia Therapeutics is a genome editing company that caters to the biotechnology industry.
View companyCRISPR Therapeutics
HQ
Zug, CH
Employees
393
CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
View company